MedTrace Logo

BlueWind Medical System for the Treatment of Patients With OAB

NCT02299544 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2019-06-18

No results posted yet for this study

Summary

BlueWind system safety and performance in treatment of patients diagnosed with overactive bladder (OAB)

Conditions

  • Over Active Bladder

Interventions

DEVICE

BlueWind Medical system

The BlueWind Medical System is intended for the treatment of patients with overactive bladder (OAB) including urinary urgency frequency and urge incontinence.

Sponsors & Collaborators

  • BlueWind Medical

    lead INDUSTRY

Principal Investigators

  • John Heesakkers, MD · Principal Investigator

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2018-08-31
Completion
2018-12-31

Countries

  • Netherlands
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02299544 on ClinicalTrials.gov